Yi-Ting Tsai - Publications

Affiliations: 
Columbia University, New York, NY 
Area:
Ophthalmolohy

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chang YJ, Xu CL, Cui X, Bassuk AG, Mahajan VB, Tsai YT, Tsang SH. CRISPR Base Editing in Induced Pluripotent Stem Cells. Methods in Molecular Biology (Clifton, N.J.). PMID 31250381 DOI: 10.1007/7651_2019_243  0.312
2019 Sancho-Pelluz J, Cui X, Lee W, Tsai YT, Wu WH, Justus S, Washington I, Hsu CW, Park KS, Koch S, Velez G, Bassuk AG, Mahajan VB, Lin CS, Tsang SH. Mechanisms of neurodegeneration in a preclinical autosomal dominant retinitis pigmentosa knock-in model with a Rho mutation. Cellular and Molecular Life Sciences : Cmls. PMID 30976840 DOI: 10.1007/S00018-019-03090-9  0.35
2018 Zhang L, Cui X, Jauregui R, Park KS, Justus S, Tsai YT, Duong JK, Hsu CW, Wu WH, Xu CL, Lin CS, Tsang SH. Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30001913 DOI: 10.1016/J.Ymthe.2018.06.014  0.342
2018 Tsai YT, Wu WH, Lee TT, Wu WP, Xu CL, Park KS, Cui X, Justus S, Lin CS, Jauregui R, Su PY, Tsang SH. Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa. Ophthalmology. PMID 29759820 DOI: 10.1016/J.Ophtha.2018.04.001  0.354
2018 Wu WH, Tsai YT, Justus S, Cho GY, Sengillo JD, Xu Y, Cabral T, Lin CS, Bassuk AG, Mahajan VB, Tsang SH. CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology. Methods in Molecular Biology (Clifton, N.J.). 1715: 191-205. PMID 29188514 DOI: 10.1007/978-1-4939-7522-8_13  0.329
2017 Velez G, Tsang SH, Tsai YT, Hsu CW, Gore A, Abdelhakim AH, Mahajan M, Silverman RH, Sparrow JR, Bassuk AG, Mahajan VB. Gene Therapy Restores Mfrp and Corrects Axial Eye Length. Scientific Reports. 7: 16151. PMID 29170418 DOI: 10.1038/S41598-017-16275-8  0.363
2017 Koch SF, Duong JK, Hsu CW, Tsai YT, Lin CS, Wahl-Schott CA, Tsang SH. Genetic rescue models refute nonautonomous rod cell death in retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America. PMID 28468800 DOI: 10.1073/Pnas.1615394114  0.379
2016 Sengillo JD, Justus S, Tsai YT, Cabral T, Tsang SH. Gene and cell-based therapies for inherited retinal disorders: An update. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. PMID 27862925 DOI: 10.1002/Ajmg.C.31534  0.374
2016 Zhang L, Du J, Justus S, Hsu CW, Bonet-Ponce L, Wu WH, Tsai YT, Wu WP, Jia Y, Duong JK, Mahajan VB, Lin CS, Wang S, Hurley JB, Tsang SH. Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration. The Journal of Clinical Investigation. 126: 4659-4673. PMID 27841758 DOI: 10.1172/Jci86905  0.382
2016 Wu WH, Tsai YT, Justus S, Lee T, Zhang L, Lin CS, Bassuk AG, Mahajan VB, Tsang SH. CRISPR repair reveals causative mutation in a preclinical model of retinitis pigmentosa. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27203441 DOI: 10.1038/Mt.2016.107  0.356
2015 Koch SF, Tsai YT, Duong JK, Wu WH, Hsu CW, Wu WP, Bonet-Ponce L, Lin CS, Tsang SH. Halting progressive neurodegeneration in advanced retinitis pigmentosa. The Journal of Clinical Investigation. 125: 3704-13. PMID 26301813 DOI: 10.1172/Jci82462  0.378
2014 Yang J, Li Y, Chan L, Tsai YT, Wu WH, Nguyen HV, Hsu CW, Li X, Brown LM, Egli D, Sparrow JR, Tsang SH. Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. Human Molecular Genetics. 23: 3445-55. PMID 24497574 DOI: 10.1093/Hmg/Ddu053  0.311
2013 Davis RJ, Hsu CW, Tsai YT, Wert KJ, Sancho-Pelluz J, Lin CS, Tsang SH. Therapeutic margins in a novel preclinical model of retinitis pigmentosa. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 13475-83. PMID 23946405 DOI: 10.1523/Jneurosci.0419-13.2013  0.381
2012 Yang J, Naumann MC, Tsai YT, Tosi J, Erol D, Lin CS, Davis RJ, Tsang SH. Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors. Plos One. 7: e43889. PMID 22970106 DOI: 10.1371/Journal.Pone.0043889  0.349
2012 Li Y, Tsai YT, Hsu CW, Erol D, Yang J, Wu WH, Davis RJ, Egli D, Tsang SH. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Molecular Medicine (Cambridge, Mass.). 18: 1312-9. PMID 22895806 DOI: 10.2119/Molmed.2012.00242  0.329
Show low-probability matches.